Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies Inc. Message Board

arodbronx 3 posts  |  Last Activity: Jun 26, 2015 8:43 PM Member since: Aug 3, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • arodbronx arodbronx Jun 26, 2015 8:43 PM Flag

    Lots of dim bulbs posting on this board. All buyers of the offering have been disclosed by Arca in SEC filings.

    Venrock Healthcare Capital Partners II, L.P. 5,373,623
    VHCP Co-Investment Holdings II, LLC 2,178,904
    Venrock Healthcare Capital Partners, L.P. 2,736,388
    VHCP Co-Investment Holdings, LLC 500,409
    Growth Equity Opportunities Fund IV, LLC 10,221,465
    Franklin Biotechnology Discovery Fund 3,346,547
    Franklin Templeton Investment Funds 5,171,341
    RA Capital Healthcare Fund, L.P. 4,673,481
    Blackwell Partners LLC – Series A 1,005,111
    Tekla Life Sciences Investors 5,678,592
    Capital Ventures International 567,859
    DAFNA LifeScience L.P. 323,680
    DAFNA LifeScience Market Neutral L.P. 22,714

  • ABIO investors from the most recent SEC filing:

    Venrock Healthcare Capital Partners II, L.P. 5,373,623
    VHCP Co-Investment Holdings II, LLC 2,178,904
    Venrock Healthcare Capital Partners, L.P. 2,736,388
    VHCP Co-Investment Holdings, LLC 500,409
    Growth Equity Opportunities Fund IV, LLC 10,221,465
    Franklin Biotechnology Discovery Fund 3,346,547
    Franklin Templeton Investment Funds 5,171,341
    RA Capital Healthcare Fund, L.P. 4,673,481
    Blackwell Partners LLC – Series A 1,005,111
    Tekla Life Sciences Investors 5,678,592
    Capital Ventures International 567,859
    DAFNA LifeScience L.P. 323,680
    DAFNA LifeScience Market Neutral L.P. 22,714

    The first four on the list are all part of Venrock, one of the most successful venture capital firms in history: 10,221,465 shares.
    The next, Growth Equities Opportunities Fund, is part of New Enterprise Associates, also one of the most success venture capital firms in US history: 10,221,465 shares.
    Franklin funds: 8,517,888 shares.
    RA Capital needs no introduction. They're one of the most famous biotech investors, even more successful than Baker Brothers: 4,673,481 shares.
    Blackwell Partners: 1,005,111 shares
    Tekla Life Sciences Investors is a closed-end investment fund traded on the NYSE:5,678,592 shares.
    Capital Ventures International: 567,859 shares.
    DAFNA invests in publicly traded biotechnology: 346, 394 shares.

  • arodbronx arodbronx Jun 14, 2015 8:12 AM Flag

    Drugs often have multiple designation. Janssen/Pharmacyclic’s ibrutinib (Imbruvica) has five: Orphan Drug, Fast Track, Breakthrough, Priority Review and Accellerated Approval. Google this: Novel and New Drugs 2014 Summary - Food and Drug Administration. The first result should be a PDF file. Click on it and scroll down to page 13. It will show you all the drugs approved by FDA’s CDER division in 2014 and the multiple designations each has.

SIGA
2.460.00(0.00%)Mar 13 4:00 PMEDT